Xth Eurasian Hematology-Oncology Congress

http://www.ehog.net/

 

Xth Eurasian Hematology-Oncology Congress
M

What is the Role and Best Sequencing of the New Generation Hormonal Agents in the Treatment of Castration Resistant (non)Metastatic Prostate Cancer?

By Xth Eurasian Hematology-Oncology Congress FEATURING Mustafa Erman
By Xth Eurasian Hematology-Oncology Congress FEATURING Mustafa Erman
0 views
December 4, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Genitourinary
18:54
Xth Eurasian Hematology-Oncology Congress

Stage I Testicular Cancer: Who Needs Treatment and Which One?

Feat. O. Dizdar
14:30
Xth Eurasian Hematology-Oncology Congress

How to Treat Cisplatin-Ineligible Metastatic Bladder Cancer: CPi Str…

Feat. A. Karaoglu
06:15
Xth Eurasian Hematology-Oncology Congress

How to Treat Cisplatin-Ineligible Metastatic Bladder Cancer: Non-Cis…

Feat. A. Karaoglu
16:18
Xth Eurasian Hematology-Oncology Congress

What is the Role and Best Sequencing of the New Generation Hormonal …

Feat. M. Erman
17:28
Xth Eurasian Hematology-Oncology Congress

What is the Role and Best Sequencing of the New Generation Hormonal …

Feat. M. Erman
26:23
Xth Eurasian Hematology-Oncology Congress

Perioperative Systemic Therapy for Localized Renal Cell Carcinoma: T…

Feat. C. Arslan